이상반응 보고
| VAERS ID | 2247520 |
|---|---|
| 성별 | 남성 |
| 나이 | 43세 |
| 주 코드 | FR |
| 제약회사 | MODERNA |
| 로트 번호 | |
| 예방접종 횟수 | 1 |
| 접종일 | 2022-03-22 |
| 발병일 | 2022-03-22 |
| 상태 | 입원 |
증상
- 사지의 통증(Pain in extremity)
- 발열(Pyrexia)
- 무력증(Asthenia)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
Limb pain; Fever; Weakness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Apr-2022 and was forwarded to Moderna on 13-Apr-2022.
This regulatory authority case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Limb pain), PYREXIA (Fever) and ASTHENIA (Weakness) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.
No Medical History information was reported.
On 22-Mar-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.
On 22-Mar-2022, the patient experienced PAIN IN EXTREMITY (Limb pain) (seriousness criterion hospitalization), PYREXIA (Fever) (seriousness criterion hospitalization) and ASTHENIA (Weakness) (seriousness criterion hospitalization).
At the time of the report, PAIN IN EXTREMITY (Limb pain), PYREXIA (Fever) and ASTHENIA (Weakness) was resolving.
The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
No concomitant medication information was provided.
On 22-Mar-2022, the first season of Moderna vaccine was administered and on that day, general soreness, weakness and fever occurred Company comment: This regulatory case concerns a 43-year-old male patient, with no reported medical history, who experienced, unexpected, serious (Hospitalized) events of Pain in extremity, Pyrexia and Asthenia, the same day after receiving a dose of mRNA-1273 vaccine.
The patient reported occurrence of general soreness, weakness and fever.
Two days after the onset of symptoms, the patient sough medical consult and was subsequently admitted.
The diagnosis at that time was fever and headache.
Clinical course and treatment details are not available in this report.
Approximately 2 weeks after admission, the patient was discharged.
At the time of the report, the events were resolving.
The benefit-risk relationship of mRNA-1273 is not affected by this report.
Event's seriousness was assessed as per Regulatory Authority's report.
.
On 24-Mar-2022, the patient came to hospital for emergency treatment and was admitted to the hospital.
Diagnosis was reported as fever and headache.
On 29-Mar-2022, a notice was received to inform the patient of that the vaccine might cause adverse reactions.
On 06-Apr-2022, the patient was discharged.
No treatment medication was provided.
; Sender's Comments: This regulatory case concerns a 43-year-old male patient, with no reported medical history, who experienced, unexpected, serious (Hospitalized) events of Pain in extremity, Pyrexia and Asthenia, the same day after receiving a dose of mRNA-1273 vaccine.
The patient reported occurrence of general soreness, weakness and fever.
Two days after the onset of symptoms, the patient sough medical consult and was subsequently admitted.
The diagnosis at that time was fever and headache.
Clinical course and treatment details are not available in this report.
Approximately 2 weeks after admission, the patient was discharged.
At the time of the report, the events were resolving.
The benefit-risk relationship of mRNA-1273 is not affected by this report.
Event's seriousness was assessed as per Regulatory Authority's report.